Gene editing company Inscripta’s vision is to “operationalize” biology with its CRISPR-powered tools. It got one step closer today with the announcement of $20M in additional Series C funding, bringing their Series C to...
Author - Marianna Limas
Digest #253 – $1.2 billion in 1 week: Moderna $604M IPO, Zymergen $400M, Synthorx $131M IPO, Synthace $25.6M, Elemental Machines $9M, GenEdit $8.5M + our early bird ends Friday!
Your guide to what’s new in synthetic biology Hi all, It’s been a phenomenal week for the synthetic biology industry with $1.2B flowing into the industry from a couple of big IPOs and some big new funding...
News digest #252 – iGEM teams find success with lab automation and cell-free expression, tips for building your biotech startup team (12/5/2018)
Your guide to what’s new in synthetic biology Hi all, Synthetic biology is about to close out a record year, and 2019 promises to be even bigger. Are you hiring? We have a recruitment promotion on right...
Launching the SynBioBeta Digital Biology Newsletter, Issue #1
Hi all, Welcome to issue #1 of our new Digital Biology Newsletter! I’ve been hearing from many readers that you’d like more content about the growing power of digital biology, so today we’re launching a...
Checkerspot raises $5M to bring new high performance sustainable materials from microalgae
For millennia, civilization has depended on a handful of plant oils for food, medicine, and agriculture, including canola, soy, peanut, coconut, palm, corn, sunflower, and olive oil. Today, these same natural...
Learning from Nature to Develop new Organisms that Replace Technology with Biology
This week we interviewed Jason Kelly, CEO and Co-Founder of Ginkgo Bioworks, who will be giving a keynote talk at SynBioBeta SF 2017 on October 3rd. Ginkgo recently announced the creation of a new company with Bayer...
Synthetic Biology and Immunotherapy to Bring More Effective Cell Therapies for Cancer
For years, the foundations of cancer treatment were chemotherapy, surgery, and radiation therapy. But over the past several years, progress with therapies that collect and use a patient’s own immune cells to attack...
Meet Laura Adam, an Expert in Design Automation in Synthetic Biology
This week we interviewed Laura Adam, who will be speaking in the Computation and Synthetic Biology session (Sponsored by Amazon Web Services) at SynBioBeta SF 2017. She is an expert in the field of synthetic biology...
A New Enzymatic Approach to DNA Synthesis Could be the Next Breakthrough in Synthetic Biology
The Molecular Assemblies story began more than 30 years ago when Dr. J. William Efcavitch and Curt Becker recognized the limitations of the chemical-based method of DNA synthesis. The process relies on harsh chemicals...
New Bioinspired Materials: Why AMSilk is Betting on Bioengineered Silk Polymers
Scientists have tried to mass-produce spider silk for decades with little success. As a naturally occurring supermaterial, spider silk is strong, extendible, lightweight, biodegradable, flexible, biocompatible, and can...
